These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32625670)

  • 1. The principles and methods behind EFSA's Guidance on Uncertainty Analysis in Scientific Assessment.
    ; Benford D; Halldorsson T; Jeger MJ; Knutsen HK; More S; Naegeli H; Noteborn H; Ockleford C; Ricci A; Rychen G; Schlatter JR; Silano V; Solecki R; Turck D; Younes M; Craig P; Hart A; Von Goetz N; Koutsoumanis K; Mortensen A; Ossendorp B; Germini A; Martino L; Merten C; Mosbach-Schulz O; Smith A; Hardy A
    EFSA J; 2018 Jan; 16(1):e05122. PubMed ID: 32625670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidance on Uncertainty Analysis in Scientific Assessments.
    ; Benford D; Halldorsson T; Jeger MJ; Knutsen HK; More S; Naegeli H; Noteborn H; Ockleford C; Ricci A; Rychen G; Schlatter JR; Silano V; Solecki R; Turck D; Younes M; Craig P; Hart A; Von Goetz N; Koutsoumanis K; Mortensen A; Ossendorp B; Martino L; Merten C; Mosbach-Schulz O; Hardy A
    EFSA J; 2018 Jan; 16(1):e05123. PubMed ID: 32625671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidance on Communication of Uncertainty in Scientific Assessments.
    ; Hart A; Maxim L; Siegrist M; Von Goetz N; da Cruz C; Merten C; Mosbach-Schulz O; Lahaniatis M; Smith A; Hardy A
    EFSA J; 2019 Jan; 17(1):e05520. PubMed ID: 32626067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Draft for internal testing Scientific Committee guidance on appraising and integrating evidence from epidemiological studies for use in EFSA's scientific assessments.
    ; More S; Bambidis V; Benford D; Bragard C; Hernandez-Jerez A; Bennekou SH; Koutsoumanis K; Machera K; Naegeli H; Nielsen SS; Schlatter JR; Schrenk D; Silano V; Turck D; Younes M; Fletcher T; Greiner M; Ntzani E; Pearce N; Vinceti M; Ciccolallo L; Georgiadis M; Gervelmeyer A; Halldorsson TI
    EFSA J; 2020 Aug; 18(8):e06221. PubMed ID: 32831946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific Committee guidance on appraising and integrating evidence from epidemiological studies for use in EFSA's scientific assessments.
    ; More S; Bampidis V; Benford D; Bragard C; Hernandez-Jerez A; Bennekou SH; Koutsoumanis K; Lambré C; Machera K; Mennes W; Mullins E; Nielsen SS; Schlatter J; Schrenk D; Turck D; Younes M; Fletcher T; Greiner M; Ntzani E; Pearce N; Vinceti M; Vrijheid M; Georgiadis M; Gervelmeyer A; Halldorsson TI
    EFSA J; 2024 Jul; 22(7):e8866. PubMed ID: 38974922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidance on the use of the weight of evidence approach in scientific assessments.
    ; Hardy A; Benford D; Halldorsson T; Jeger MJ; Knutsen HK; More S; Naegeli H; Noteborn H; Ockleford C; Ricci A; Rychen G; Schlatter JR; Silano V; Solecki R; Turck D; Benfenati E; Chaudhry QM; Craig P; Frampton G; Greiner M; Hart A; Hogstrand C; Lambre C; Luttik R; Makowski D; Siani A; Wahlstroem H; Aguilera J; Dorne JL; Fernandez Dumont A; Hempen M; Valtueña Martínez S; Martino L; Smeraldi C; Terron A; Georgiadis N; Younes M
    EFSA J; 2017 Aug; 15(8):e04971. PubMed ID: 32625632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of risk assessment and predictive microbiology in regulatory science related to the scientific opinions of the EFSA BIOHAZ Panel.
    Messens W; Bover-Cid S; Hempen M; Lindqvist R; Nauta M; Skandamis PN; Stella P; Koutsoumanis K
    Int J Food Microbiol; 2023 Oct; 403():110302. PubMed ID: 37392608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidance for establishing and applying tolerable upper intake levels for vitamins and essential minerals: Draft for internal testing.
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Peláez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Aggett P; Crous Bou M; Cubadda F; de Sesmaisons Lecarré A; Martino L; Naska A
    EFSA J; 2022 Jan; 20(1):e200102. PubMed ID: 35106096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidance on protocol development for EFSA generic scientific assessments.
    ; More S; Bampidis V; Benford D; Bragard C; Hernández-Jerez A; Bennekou SH; Koutsoumanis KP; Lambré C; Machera K; Mullins E; Nielsen SS; Schlatter J; Schrenk D; Turck D; Younes M; Kraft A; Naegeli H; Tsaioun K; Aiassa E; Arcella D; Barizzone F; Cushen M; Georgiadis M; Gervelmeyer A; Lanzoni A; Lenzi P; Lodi F; Martino L; Messens W; Ramos Bordajandi L; Rizzi V; Stancanelli G; Supej Š; Halldorsson TI
    EFSA J; 2023 Oct; 21(10):e08312. PubMed ID: 37908452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EFSA's framework for evidence-based scientific assessments: A case study on uncertainty analysis.
    Aiassa E; Merten C; Martino L
    ALTEX; 2022; 39(3):451–462. PubMed ID: 34185094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EFSA's scientific activities and achievements on the risk assessment of genetically modified organisms (GMOs) during its first decade of existence: looking back and ahead.
    Devos Y; Aguilera J; Diveki Z; Gomes A; Liu Y; Paoletti C; du Jardin P; Herman L; Perry JN; Waigmann E
    Transgenic Res; 2014 Feb; 23(1):1-25. PubMed ID: 23963741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study on uncertainty analysis in EFSA Reasoned Opinions on the modification of pesticide maximum residue levels.
    ; Pedersen R
    EFSA J; 2017 Jul; 15(7):e04906. PubMed ID: 32625567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scientific motivations and criteria to consider updating EFSA scientific assessments.
    ; Hardy A; Benford D; Halldorsson T; Jeger MJ; Knutsen KH; More S; Mortensen A; Naegeli H; Noteborn H; Ockleford C; Ricci A; Rychen G; Schlatter JR; Silano V; Solecki R; Turck D; Brock T; Chesson A; Karenlampi S; Lambre C; Sanz Y; Goumperis T; Kleiner J; Maurici D
    EFSA J; 2017 Mar; 15(3):e04737. PubMed ID: 32625443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidance on harmonised methodologies for human health, animal health and ecological risk assessment of combined exposure to multiple chemicals.
    ; More SJ; Bampidis V; Benford D; Bennekou SH; Bragard C; Halldorsson TI; Hernández-Jerez AF; Koutsoumanis K; Naegeli H; Schlatter JR; Silano V; Nielsen SS; Schrenk D; Turck D; Younes M; Benfenati E; Castle L; Cedergreen N; Hardy A; Laskowski R; Leblanc JC; Kortenkamp A; Ragas A; Posthuma L; Svendsen C; Solecki R; Testai E; Dujardin B; Kass GE; Manini P; Jeddi MZ; Dorne JC; Hogstrand C
    EFSA J; 2019 Mar; 17(3):e05634. PubMed ID: 32626259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the editor regarding the article 'EFSA's toxicological assessment of aspartame: was it even-handedly trying to identify possible unreliable positives and unreliable negatives?'.
    Kass GEN; Lodi F
    Arch Public Health; 2020; 78():14. PubMed ID: 32266067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When the weight of evidence does not weigh enough: EFSA's draft scientific opinion on BPA.
    Zagorski JW; Kaminski NE
    Toxicol Sci; 2023 May; 193(2):115-118. PubMed ID: 37052529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EFSA's toxicological assessment of aspartame: was it even-handedly trying to identify possible unreliable positives and unreliable negatives?
    Millstone EP; Dawson E
    Arch Public Health; 2019; 77():34. PubMed ID: 31338189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EFSA's third Scientific Conference 'Science, Food, Society': concluding remarks.
    Verhagen H; Robinson T; Gallani B; Hugas M; Kleiner J; Hardy A; Devos Y
    EFSA J; 2019 Jul; 17(Suppl 1):e170723. PubMed ID: 32626459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Assessment of Combined Exposure to Multiple Chemicals at the European Food Safety Authority: Principles, Guidance Documents, Applications and Future Challenges.
    Cattaneo I; Kalian AD; Di Nicola MR; Dujardin B; Levorato S; Mohimont L; Nathanail AV; Carnessechi E; Astuto MC; Tarazona JV; Kass GEN; Liem AKD; Robinson T; Manini P; Hogstrand C; Price PS; Dorne JLCM
    Toxins (Basel); 2023 Jan; 15(1):. PubMed ID: 36668860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opinion on the impact of non-monotonic dose responses on EFSA's human health risk assessments.
    ; More S; Benford D; Hougaard Bennekou S; Bampidis V; Bragard C; Halldorsson T; Hernandez-Jerez A; Koutsoumanis K; Lambré C; Machera K; Mullins E; Nielsen SS; Schlatter J; Schrenk D; Turck D; Tarazona J; Younes M
    EFSA J; 2021 Oct; 19(10):e06877. PubMed ID: 34712366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.